A Randomized, Double-Blind, Placebo-Controlled, Four-Way Crossover Study on Itch Control by VLY-686 Administration in Healthy Volunteers After Intradermal Injections of Substance P
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2015
Price : $35 *
At a glance
- Drugs Tradipitant (Primary)
- Indications Pruritus; Urticaria
- Focus Therapeutic Use
- Sponsors Vanda Pharmaceuticals
- 24 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Dec 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Nov 2013 New trial record